You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Digestive tract conditions
  5. Inflammatory bowel disease

Infliximab for acute exacerbations of ulcerative colitis

  • Technology appraisal guidance
  • Reference number: TA163
  • Published:  17 December 2008
  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

Ulcerative colitis (acute exacerbations) - infliximab: Consultee and commentator comments on the ACD

  • Ulcerative colitis (acute exacerbations) - infliximab: FAD comments - Department of Health

  • Ulcerative colitis (acute exacerbations) - infliximab: FAD comments - National Association for Colitis and Crohn's Disease

  • Ulcerative colitis (acute exacerbations) - infliximab: FAD comments - Royal College of Nurses

  • Ulcerative colitis (acute exacerbations) - infliximab: FAD comments - Royal College of Pathologists

  • Ulcerative colitis (acute exacerbations) - infliximab: FAD comments - Royal College of Physicians

  • Ulcerative colitis (acute exacerbations) - infliximab: FAD comments - Schering Plough


This page was last updated: 30 March 2010

Back to top